Surface-Modified Silver Nanoparticles and Their Encapsulation in Liposomes Can Treat MCF-7 Breast Cancer Cells
Source abstract
Abstract
Silver nanoparticles (AgNPs) have emerged as a promising tool for cancer treatment due to their unique physicochemical and biological properties. However, their clinical applications are limited by their potential cytotoxicity caused due to oxidation stress and non-specific cellular uptake pathways. To overcome these barriers, surface modifications of AgNPs have been proposed as an effective strategy to enhance their biocompatibility and specificity toward cancer cells. In this study, AgNPs were synthesised using the chemical reduction method and subsequently conjugated with various capping agents such as Polyvinylpyrrolidone (PVP) and Bovine Serum Albumin (BSA). Further, this study involves the synthesis of liposomes by using dipalmitoyl phosphatidylcholine lipid (DPPC) and cholesterol to increase the biocompatibility and bioavailability of AgNPs to MCF-7 breast cancer cells. In vitro, cytotoxicity studies were performed to determine which surface modification method exhibited the highest cytotoxic effect on the MCF-7 breast cancer cells, which was determined through the MTT assay. The AgNPs conjugated with BSA exhibited the highest cytotoxicity at the lowest dosage, with an IC50 of 2.5 μL/mL. The BSA-AgNPs induced a dose-dependent rise in cytotoxicity through the enhancement of nucleophilic dissolution of the AgNPs in cancer cells. In comparison, the unmodified AgNPs had an IC50 value of 3.0 μL/mL, while the PVP-modified AgNPs had an IC50 of 4.24 μL/mL. AgNPs encapsulated in liposomes had an IC50 value of 5.08 μL/mL, which shows that the encapsulation of AgNPs in liposomes controls their entry into cancer cells. The findings of this research have provided insights into the potential use of surface-modified AgNPs and liposomal encapsulated AgNPs as novel therapeutic tools to overcome the conventional treatment limitations of breast cancer cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Food Science and Environmental Health, College of Sciences and Health, Technological University Dublin, D07 H6K8 Dublin, Ireland
Nanolab, FOCAS Research Institute, Technological University Dublin, D08 CKP1 Dublin, Ireland
RELX Elsevier, D18 X6N2 Dublin, Ireland
References (39)
Show source-provided references
1. Advanced Drug Delivery System with Nanomaterials for Personalised Medicine to Treat Breast Cancer10.1016/j.jddst.2019.05.024 ↗
2. Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies Supplementary Issue: Targeted Therapies in Breast Cancer Treatment
3. Combination Drug Delivery Approaches in Metastatic Breast Cancer10.1155/2012/915375 ↗
4. Peptide-Capped Au and Ag Nanoparticles: Detection of Heavy Metals and Photochemical Core/Shell Formation10.1016/j.jcis.2022.10.154 ↗
5. Liposomal Encapsulation of Silver Nanoparticles Enhances Cytotoxicity and Causes Induction of Reactive Oxygen Species-Independent Apoptosis10.1002/jat.3566 ↗
6. Silver Nanoparticles Elicited Physiological, Biochemical, and Antioxidant Modifications in Rice Plants to Control Aspergillus Flavus10.1515/gps-2021-0034 ↗
7. Silver Nanoparticles: Synthesis, Characterisation and Biomedical Applications10.1515/biol-2020-0094 ↗
8. Size-Controlled Silver Nanoparticles Synthesized over the Range 5–100 Nm Using the Same Protocol and Their Antibacterial Efficacy10.1039/C3RA44507K ↗
9. Study of Interaction of Silver Nanoparticles with Bovine Serum Albumin Using Fluorescence Spectroscopy10.1007/s10895-011-0922-3 ↗
10. Surface Modification of Gold Nanoparticles with Small Molecules for Biochemical Analysis10.1021/acs.accounts.6b00506 ↗
11. Surface Modification of Fe2O3 and MgO Nanoparticles with Agrowastes for the Treatment of Chlorosis in Glycine Max10.1186/s40580-018-0155-0 ↗
12. Polyvinylpyrrolidone (PVP) in Nanoparticle Synthesis10.1039/C5DT02964C ↗
13. Effects of Chain Length of Polyvinylpyrrolidone for the Synthesis of Silver Nanostructures by a Microwave-Polyol Method10.1016/j.matlet.2005.10.027 ↗
14. Kim, D., Amatya, R., Hwang, S., Lee, S., Min, K.A., and Shin, M.C. (2021). BSA-Silver Nanoparticles: A Potential Multimodal Therapeutics for Conventional and Photothermal Treatment of Skin Cancer. Pharmaceutics, 13.10.3390/pharmaceutics13040575 ↗
15. Bovine Serum Albumin Enhances Silver Nanoparticle Dissolution Kinetics in a Size-and Concentration-Dependent Manner10.1021/acs.langmuir.9b03251 ↗
16. Evaluation of Silver Nanoparticle Encapsulation in DPPC-Based Liposome by Different Methods for Enhanced Cytotoxicity10.1080/00914037.2019.1626390 ↗
17. Olusanya, T., Ahmad, R.H., Ibegbu, D.M., Smith, J.R., and Elkordy, A.A. (2018). Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules, 23.10.3390/molecules23040907 ↗
18. Biosynthesis of Bimetallic Au-Ag Nanoparticles Using Escherichia Coli and Its Biomedical Applications10.1021/acsbiomaterials.9b01297 ↗
19. Antibacterial, Antibiofilm, Antiquorum Sensing, Antimotility, and Antioxidant Activities of Green Fabricated Ag, Cu, TiO2, ZnO, and Fe3O4 NPs via Protoparmeliopsis Muralis Lichen Aqueous Extract against Multi-Drug-Resistant Bacteria10.1021/acsbiomaterials.9b00274 ↗
20. Biogenic Ag Nanoparticles from Neem Extract: Their Structural Evaluation and Antimicrobial Effects against Pseudomonas Nitroreducens and Aspergillus Unguis (NII 08123)10.1021/acsbiomaterials.9b01257 ↗
21. Synergistic Response of Physicochemical Reaction Parameters on Biogenesis of Silver Nanoparticles and Their Action against Colon Cancer and Leishmanial Cells10.1080/21691401.2020.1850467 ↗
22. Synergistic Effects of Physicochemical Parameters on Bio-Fabrication of Mint Silver Nanoparticles: Structural Evaluation and Action Against HCT116 Colon Cancer Cells10.2147/IJN.S254402 ↗
23. Adsorption of Polyvinylpyrrolidone on Ag Surfaces: Insight into a Structure-Directing Agent10.1021/nl2041113 ↗
24. Zhang, X.F., Liu, Z.G., Shen, W., and Gurunathan, S. (2016). Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int. J. Mol. Sci., 17.10.3390/ijms17091534 ↗
25. Clinical Use of Albumin
26. The Dissolution and Biological Effects of Silver Nanoparticles in Biological Media10.1039/c3tb21569e ↗
27. Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., and Mozafari, M.R. (2018). Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics, 10.10.3390/pharmaceutics10020057 ↗
28. Zeta Potential Measurement10.1007/978-1-60327-198-1_6 ↗
29. M, J.F., and P, L. (2015). Apoptotic Efficacy of Biogenic Silver Nanoparticles on Human Breast Cancer MCF-7 Cell Lines. Prog. Biomater., 4.10.1007/s40204-015-0042-2 ↗
30. Epidermal Growth Factor-Labeled Liposomes as a Way to Target the Toxicity of Silver Nanoparticles into EGFR-Overexpressing Cancer Cells in Vitro10.1016/j.taap.2022.116009 ↗
31. Characterization of Silver Ion Dissolution from Silver Nanoparticles Using Fluorous-Phase Ion-Selective Electrodes and Assessment of Resultant Toxicity to Shewanella Oneidensis10.1039/c3sc50320h ↗
32. Negligible Particle-Specific Toxicity Mechanism of Silver Nanoparticles: The Role of Ag+ Ion Release in the Cytosol10.1016/j.nano.2014.11.002 ↗
33. Controlled Evaluation of the Impacts of Surface Coatings on Silver Nanoparticle Dissolution Rates10.1021/acs.est.7b05622 ↗
34. Nogueira, D.R., Mitjans, M., Rolim, C.M.B., and Vinardell, M.P. (2014). Mechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of In Vitro Studies. Nanomaterials, 4.10.3390/nano4020454 ↗
35. A Gold Nanoparticle and Aflatoxin B1-BSA Conjugates Based Lateral Flow Assay Method for the Analysis of Aflatoxin B110.3390/ma5040634 ↗
36. Understanding the Potential of Bio-Fabricated Non-Oxidative Silver Nanoparticles to Eradicate Leishmania and Plant Bacterial Pathogens10.1007/s13204-020-01355-5 ↗
37. One-Pot Phytosynthesis of Nano-Silver from Mentha longifolia L.: Their Characterization and Evaluation of Photodynamic Potential10.1088/2053-1591/ab903b ↗
38. In Vitro Toxicity of Nanoparticles in BRL 3A Rat Liver Cells10.1016/j.tiv.2005.06.034 ↗
39. Magnetic, Fluorescent and Hybrid Nanoparticles: From Synthesis to Application in Biosystems10.1016/j.msec.2019.110104 ↗